References
- Bax R. P., Bastain W., Featherstone A., Wilkinson D. M., Hutchison M., Haworth S. J. The pharmacokinetics of meropenem in volunteers. Journal of Antimicrobial Chemotherapy 1989; 24: 311–320, Suppl. A
- Bergan T., Nord C. E., Thorsteinsson S. B. Effect of meropenem on the intestinal microflora. European Journal of Clinical Microbiological and Infectious Diseases 1991; 10: 524–527
- Edwards J. R., Turner P. J., Wannop C., Withnell E. S., Grindey A. J., Nairn K. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase 1. Antimicrobial Agents and Chemotherapy 1989; 33: 218–222
- Granai F., Smart H. L., Triger D. R. A study of the penetration into bile using endoscopic retrograde cholangiography. Journal of Antimicrobial Chemotherapy 1992; 29(6)711–718
- Jones R. N., Barry A. L., Thornsberry C. In vitro studies of meropenem. Journal of Antimicrobial Chemotherapy 1989; 24(Suppl. A)9–29
- Kahan F. M., Kropp H., Sundelof J. G., Birnbaum J. Thienamycin: development of imipenem cilastatin. Journal of Antimicrobial Chemotherapy 1983; 12: 1–35, Suppl. D
- King A., Boothman C., Philips I. Comparative in vitro activity of meropenem on clinical isolates from the United Kingdom. Journal of Antimicrobial Chemotherapy 1989; 24: 31–45, Suppl. A
- Kropp H., Sundelof J. G., Hajdu R., Kahan F. M. Metabolism of thienamycin and related carbapenem antibiotics by renal dipeptidase: dehydropeptidase 1. Antimicrobial Agents and Chemotherapy 1982; 22: 62–70
- Nihlsson-Ehle I., Hutchison M., Haworth S. J., Norrby S. R. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young healthy, males. European Journal of Clinical Microbiology and Infectious Diseases 1991; 10: 85–88
- Nishioka K., Kanamaru H. 14C-labelling of a novel carbapenem antibiotic SM-7338. Journal of Labelled Compounds and Radiopharmaceuticals 1991; XXIX: 1051–1060
- Norrby S. R., Rodgers J. D., Ferber F., Jones K. H., Zacchei A. G., Weidner L. L., Demetriades J. L., Gravallese D. A., Hsieh Y.-K. Disposition of radiolabelled imipenem and cilastatin in normal human volunteers. Antimicrobial Agents and Chemotherapy 1984; 26: 707–714
- Tanio T., Nouda H., Tada E., Kohzuki T., Kato M., et al. SM-7338, a new carbapenem antibiotic: renal dehydropeptidase 1 stability and pharmacokinetics in animals. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy New York, 1987. American Society for Microbiology, Washington, DC 1987; 758: 229, Abstract
- Topham J. C., Murgatroyd L. B., Jones D. V., Goonetilleke U. R. P., Wright J. Safety evaluation of meropenem in animals: studies on the kidney. Journal of Antimicrobial Chemotherapy 1989; 24: 287–306, Suppl. A